Inventor · disambiguated record
Hartmut Ehrlich
Also filed as: EHRLICH HARTMUT
29 granted patents·18 pending applications·179 citations·filing 1987–2024
96Inventor score
Top patents by PatentIndex Score
47 records- 0194US8450275B2TFPI inhibitors and methods of useDOCKAL MICHAEL·Filed 2011·Granted May 28, 2013·13 cites·31 claims
- 0293US10201586B2TFPI inhibitors and methods of useBaxalta GmbH·Filed 2016·Granted Feb 12, 2019·10 cites·17 claims
- 0388US8466108B2TFPI inhibitors and methods of useDOCKAL MICHAEL·Filed 2009·Granted Jun 18, 2013·10 cites·5 claims
- 0487US4992373AVectors and compounds for direct expression of activated human protein CLILLY CO ELI·Filed 1987·Granted Feb 12, 1991·66 cites·17 claims
- 0584US7968293B2IVIG modulation of chemokines for treatment of multiple sclerosis, alzheimer's disease, and parkinson's diseaseBAXTER INT·Filed 2008·Granted Jun 28, 2011·10 cites·13 claims
- 0683US9512198B2FVIII peptides for immune tolerance induction and immunodiagnosticsBAXALTA INC·Filed 2015·Granted Dec 6, 2016·5 cites·20 claims
- 0782US11001613B2TFPI inhibitors and methods of useBaxalta GmbH·Filed 2017·Granted May 11, 2021·1 cites·33 claims
- 0881US9018167B2TFPI inhibitors and methods of useBAXTER INT·Filed 2013·Granted Apr 28, 2015·3 cites·16 claims
- 0981US8962912B2Transgenic non-human animals expressing human blood clotting factors and uses thereofSASGARY MARIA·Filed 2011·Granted Feb 24, 2015·11 cites·11 claims
- 1079US8216793B2Detection of antibody that binds to water soluble polymer-modified polypeptidesLUBICH CHRISTIAN·Filed 2010·Granted Jul 10, 2012·5 cites·13 claims
- 1177US9463237B2Recombinant viral vectors and methods for inducing a heterosubtypic immune response to influenza A virusesFalkner Falko-Günter·Filed 2012·Granted Oct 11, 2016·4 cites·3 claims
- 1276US9884105B2Production of viral vaccineKISTNER OTFRIED·Filed 2009·Granted Feb 6, 2018·2 cites·23 claims
- 1376US9556230B2TFPI inhibitors and methods of useBAXTER INT·Filed 2015·Granted Jan 31, 2017·1 cites·10 claims
- 1475US10494418B2IgG stimulated remyelination of peripheral nervesBAXALTA INC·Filed 2017·Granted Dec 3, 2019·1 cites·64 claims
- 1575US8969524B2FVIII peptides for immune tolerance induction and immunodiagnosticsSTEINITZ KATHARINA NORA·Filed 2011·Granted Mar 3, 2015·5 cites·20 claims
- 1674US11793855B2TFPI inhibitors and methods of useTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Oct 24, 2023·0 cites·22 claims
- 1773US2025275994A1Quinoline Derivatives For Use In The Treatment Of Inflammation DiseasesABIVAX·Filed 2024·Application pending·0 cites
- 1873US2020216518A1IgG STIMULATED REMYELINATION OF PERIPHERAL NERVESBAXALTA INC·Filed 2019·Application pending·0 cites
- 1972US9777051B2TFPI inhibitors and methods of useBaxalta GmbH·Filed 2013·Granted Oct 3, 2017·1 cites·10 claims
- 2072US2021300997A1IgG STIMULATED REMYELINATION OF PERIPHERAL NERVESTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 2170US11826372B2Combinations including ABX196 for the treatment of cancerABIVAX·Filed 2021·Granted Nov 28, 2023·0 cites·9 claims
- 2270US9834593B2IgG stimulated remyelination of peripheral nervesBAXALTA INC·Filed 2015·Granted Dec 5, 2017·1 cites·35 claims
- 2369US11992499B2Quinoline derivatives for use in the treatment of inflammation diseasesABIVAX·Filed 2019·Granted May 28, 2024·0 cites·38 claims
- 2466US2021187105A1Combination therapy of anti-mif antibodies and glucocorticoidsBAXALTA INC·Filed 2020·Application pending·0 cites
- 2565US8986670B2IgG stimulated remyelination of peripheral nervesHEINRICH HEINE UNIVERSITÄT·Filed 2013·Granted Mar 24, 2015·1 cites·13 claims
- 2663US8852874B2Anti-amyloid β activity of intravenous immunoglobulin (IVIG) in vitroOLAS KATARZYNA·Filed 2009·Granted Oct 7, 2014·3 cites·20 claims
- 2763US5196322AVectors and compounds for expression of zymogen forms of human protein CLILLY CO ELI·Filed 1991·Granted Mar 23, 1993·25 cites·20 claims
- 2862US10329583B2Recombinant viral vectors and methods for inducing a heterosubtypic immune response to influenza A virusesOLOGY BIOSERVICES INC·Filed 2016·Granted Jun 25, 2019·1 cites·17 claims
- 2960US9046536B2Methods and compositions for treating bleeding disordersBAXTER INT·Filed 2013·Granted Jun 2, 2015·0 cites·14 claims
- 3058US11266667B2ABX196 for use in the treatment of bladder cancerABIVAX·Filed 2018·Granted Mar 8, 2022·0 cites·8 claims
- 3157US11278552B2Combinations including ABX196 for the treatment of cancerABIVAX·Filed 2017·Granted Mar 22, 2022·0 cites·10 claims
- 3256US2009235369A1Transgenic Non-Human Animals Expressing Human Blood Clotting Factors and Uses ThereofBAXTER HEALTHCARE SA·Filed 2008·Application pending·0 cites
- 3356US2022071985A1Quinoline derivatives for use in the treatment or prevention of cancerABIVAX·Filed 2019·Application pending·0 cites
- 3455US8435792B2Methods and compositions for treating bleeding disordersDOCKAL MICHAEL·Filed 2011·Granted May 7, 2013·0 cites·17 claims
- 3555US2015250873A1Combination therapy of anti-mif antibodies and glucocorticoidsBAXTER HEALTHCARE SA·Filed 2013·Application pending·0 cites
- 3654US8632991B2Methods and compositions for treating bleeding disordersDOCKAL MICHAEL·Filed 2011·Granted Jan 21, 2014·0 cites·13 claims
- 3754US2023142547A1Compounds for treating or preventing a coronaviridae infection & methods and uses for assessing the occurrence of a coronaviridae infectionABIVAX·Filed 2021·Application pending·0 cites
- 3854US2018280501A1Combination therapy of anti-mif antibodies and glucocorticoidsBAXALTA INC·Filed 2017·Application pending·0 cites
- 3953US2014255440A1Recombinant viral vectors and methods for inducing an immune response to yellow fever virusBAXTER INT·Filed 2014·Application pending·0 cites
- 4053US2022145406A1Biomarkers, and uses in treatment of viral infections, inflammations, or cancerABIVAX·Filed 2019·Application pending·0 cites
- 4148US2017267743A1Fviii peptides for immune tolerance induction and immunodiagnosticsBAXALTA INC·Filed 2016·Application pending·0 cites
- 4248US2012309021A1Detection of antibody that binds to water soluble polymer-modified polypeptidesLUBICH CHRISTIAN·Filed 2012·Application pending·0 cites
- 4345US2012328649A1Recombinant Viral Vectors and Methods for Inducing an Immune Response to Yellow Fever VirusFALKNER FALKO-GUENTER·Filed 2011·Application pending·0 cites
- 4444US2017049885A1Combination therapy of anti-mif antibodies and chemotherapeuticsBAXALTA INC·Filed 2016·Application pending·0 cites
- 4543US2015071942A1Combination therapy of anti-mif antibodies and chemotherapeuticsBAXTER HEALTHCARE SA·Filed 2013·Application pending·0 cites
- 4642US2011177094A1Ivig modulation of chemokines for treatment of multiple sclerosis, alzheimer's disease, and parkinson's diseaseBAXTER INT·Filed 2011·Application pending·0 cites
- 4737US2011159031A1Vaccine to Influenza A VirusBAXTER INT·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →